Epigenetic assays for chemical biology and drug discovery
Abstract The implication of epigenetic abnormalities in many diseases and the approval of a number of compounds that modulate specific epigenetic targets in a therapeutically relevant manner in cancer specifically confirms that some of these targets are druggable by small molecules. Furthermore, a n...
Main Author: | Sheraz Gul |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-04-01
|
Series: | Clinical Epigenetics |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13148-017-0342-6 |
Similar Items
-
A Biophysical Approach to the Identification of Novel ApoE Chemical Probes
by: Lucas Kraft, et al.
Published: (2019-01-01) -
Composition and applications of focus libraries to phenotypic assays
by: Anne Mai eWassermann, et al.
Published: (2014-07-01) -
A time-resolved fluorescence resonance energy transfer screening assay for discovery of protein-protein interaction modulators
by: Cong Tang, et al.
Published: (2021-09-01) -
PASTA: PARP activity screening and inhibitor testing assay
by: Ilsa T. Kirby, et al.
Published: (2021-03-01) -
Bioactivity Signatures of Drugs vs. Environmental Chemicals Revealed by Tox21 High-Throughput Screening Assays
by: Deborah K. Ngan, et al.
Published: (2019-12-01)